Teamit ’s Post

🌍💉 As we approach #WorldImmunisationWeek, we invite you to explore our standard in brief on the 𝐢𝐦𝐦𝐮𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐩𝐫𝐞𝐭𝐞𝐫𝐦 𝐢𝐧𝐟𝐚𝐧𝐭𝐬. ✅ Preterm infants require special protection against vaccine-preventable diseases. Regardless of their gestational age and weight at birth, they should be immunised according to their 𝐜𝐡𝐫𝐨𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐚𝐠𝐞. In very preterm infants, immunisations are started and 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐞𝐝 𝐢𝐧 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥, once the target age for the first immunisation is reached. ➡️ Ensuring that 𝐟𝐚𝐦𝐢𝐥𝐲 𝐦𝐞𝐦𝐛𝐞𝐫𝐬, household and other close contacts of preterm infants are immunised according to national recommendations is crucial. This 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐯𝐞 𝐜𝐨𝐧𝐜𝐞𝐩𝐭, known as "𝐜𝐨𝐜𝐨𝐨𝐧𝐢𝐧𝐠", helps reduce the risk of transmitting vaccine-preventable diseases like pertussis or influenza. 🏥💉 𝐖𝐨𝐫𝐥𝐝 𝐈𝐦𝐦𝐮𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧 𝐖𝐞𝐞𝐤, celebrated in the last week of April, aims to raise awareness about the value of vaccines and ensures more children, adults, and communities are protected from preventable diseases. Health services across the world play a pivotal role in 𝐬𝐚𝐟𝐞𝐠𝐮𝐚𝐫𝐝𝐢𝐧𝐠 𝐩𝐫𝐞𝐭𝐞𝐫𝐦 𝐢𝐧𝐟𝐚𝐧𝐭𝐬 and should guarantee that a national guideline on recommended preterm immunisations is available and regularly updated. 👶 Ready to dive deeper? Explore the full standard and discover the recommended immunisations for preterm infants: https://bit.ly/49e4nyb #VaccinesWork #BetterStandardsBetterOutcomes #11Months11Topics

In our latest episode of "The Pharmacists Are In," John Papastergiou and Ajit Johal wrap up their series on respiratory diseases with a focus on RSV. They explore the historical context, current impact, and emerging importance of RSV vaccination. Discover how pharmacists can prepare for the next wave of respiratory disease management. Click below for more info and to listen, or find "The Pharmacists Are In" on your favorite podcast platforms! https://lnkd.in/gwmf9bFp #RSV #RespiratoryDisease #Vaccination #Pharmacy #Pharmacist #Podcast #ThePharmacistsAreIn

📢 Stay Protected with the New RSV Vaccine! 🌟 We are now offering the Pfizer RSV vaccine, Abrysvo, at Private GP Services! This vaccine is essential for: 🌼 Adults aged 75 and over 🤰 Pregnant women who are at least 28 weeks along 💡 Why is the RSV vaccine important? Respiratory syncytial virus (RSV) can cause severe respiratory infections, especially in older adults and infants. It’s known to lead to serious health complications such as bronchiolitis and pneumonia, which can result in hospitalisation. For older adults, RSV can exacerbate underlying health conditions, leading to increased morbidity and mortality rates. For pregnant women, receiving the RSV vaccine helps protect their newborns from birth through six months of age, a critical period when infants are most vulnerable to severe RSV-related illnesses. By getting vaccinated, you can significantly reduce the risk of severe RSV infections, ensuring better health outcomes and peace of mind for you and your family. 🔗 Read more about this important update and check if you're eligible: https://buff.ly/45IfP4K Book your appointment today by calling 0330 053 3745. #RSVVaccine #Healthcare #StayProtected #PrivateGPServices

Whooping cough (also known as pertussis) is a contagious infection in the lung or breathing tube and is on the rise across Europe and some other parts of the world. It is caused by the bacterium Bordetella pertussis – although another bacterium Bordetella parapertussis can also cause it. The illness lasts for about six weeks or more and progresses through three stages. Most people eventually make a full recovery, but in babies under three months old 1% to 3% may die. And most children under six months will require hospitalisation. Those infected teenagers may suffer nothing more serious than a persistent cough. But they can still pass on what can be a fatal disease to their younger siblings - whose immunity is still forming - or indeed their grandparents, whose immunity may have faded. About one in 50 babies under one year will suffer convulsions and one in 150 (0.6%) will have encephalopathy (swelling of the brain). Other even more serious neurological problems, such as paralysis and blindness, have been reported but are rare. In older children and adults, fainting, rib fractures, pneumonia and urinary incontinence can occur. Antibiotics have limited value in treating whooping cough. They can reduce the time that the patient is infectious to others, but they have limited effect on preventing symptoms. https://lnkd.in/gRmgbKgD Vaccination for whooping cough is meant to be administered, alongside inoculation for diphtheria, tetanus, polio and others, from the very first weeks of life. Today's pertussis vaccines keep people from getting severely sick, but they don't eliminate the bacteria because it excels at colonizing, growing and persisting inside the nose. This means that despite more than 99% of people being vaccinated, whooping cough continues to spread, leading to infections among vulnerable populations, particularly infants and elderly people. The whooping cough vaccine is applied in five stages, the first three in the first 12 months of life. Almost all children receive these initial doses. However, only 90% end up receiving the final two, administered around the ages of six and ten. Like most respiratory infections, whooping cough was suppressed during the COVID years. the current rise in cases is down to a combination of two things: a resurgence in respiratory diseases as society abandons strict Covid measures; and incomplete immunisation in children. maternal pertussis immunisation is not cost-effective in Thailand. Although there may be substantial under-reporting of pertussis cases, comparison with hospital data suggests that most under-reported cases are not hospitalised and therefore have negligible impact on results. https://lnkd.in/g_JPAVAa https://lnkd.in/gXEn65wu

It's RSV Season! Know the facts to protect your patients and their families. Check out this great resource from ACOG "Seven Things to Share with Your Patients About the Maternal RSV Vaccine." https://lnkd.in/guSZyh3u

#RSV #children #hospitalization #monoclonal #antibody #effectiveness In this multisite analysis of 699 infants hospitalized with ARI during their first RSV season, receipt of nirsevimab was 90% effective against RSV-associated hospitalization at a median of 45 days from receipt of nirsevimab to ARI symptom onset. This early effectiveness estimate supports existing recommen- dations for the prevention of severe RSV disease in infants in their first RSV season. The strengths of this first estimate of U.S. post-introduction nirsevimab effectiveness include enrollment of infants using a standardized ARI definition, systematic RSV testing, and receipt of nirsevimab verification with state immunization information systems or medical records for all infants. However, it is important to note that nirsevimab effectiveness during a full RSV season is expected to be lower than the estimate reported here, because antibody levels from passive immunization wane over time. In this analysis, the median interval from receipt of nirsevimab was 45 days, whereas the median duration of the U.S. RSV season before the COVID-19 pandemic was 189 days (8). In clinical trials, nirsevimab remained highly efficacious against RSV-associated lower respiratory tract infection in infants through 150 days after receipt of nirsevimab, consistent with an extended half-life of 63–73 days (9). Estimating effectiveness under real-world conditions for the full duration of an RSV season and in children aged 8–19 months at high risk for severe RSV disease who are recommended to receive nirsevimab before their second RSV season remains important. Thus, CDC will continue to moni- tor nirsevimab effectiveness.

Important news: As people return home from holiday travel and spending time with loved ones over the past couple weeks, the Maryland Department of Health is urging clinicians to strengthen protective measures to reduce the spread of respiratory illnesses, something Choptank Community Health System is already doing in all locations. The Department of Health encourages Marylanders to take steps to reduce the spread of respiratory illnesses, according to an email from the department. The health department notes that people can receive both the updated COVID-19 vaccine and the annual flu shot at the same time. There is also a new vaccine against RSV. The CDC and Maryland Health Department both urge people to receive updated vaccines to reduce the spread of respiratory illnesses and prevent exposure to those who may have lower immune systems. The department also reminds Marylanders that washing hands, covering up a sneeze or a cough, and staying home when sick can also reduce the spread of respiratory illnesses. See the full story in The Talbot Spy here =>> https://lnkd.in/eN-qmYJA

Get vaccinated against pneumonia…before it leaves you breathless! Pneumonia, a lung infection often triggered by a bacterial or viral infection, causes the air sacs of one or both lungs to fill up with fluid and pus. This can make breathing difficult and can swiftly turn into a life-threatening condition especially for the elderly and those suffering from chronic medical conditions such as diabetes, heart, lung, kidney or liver disease.. Getting vaccinated is the best way to protect yourself and your loved ones from this disease – and now, we are offering Pneumococcal Vaccine (Prevenar 13) for the promotional price of only RM233 (NP: RM283) per dose. Kindly note that the price is valid for self-pay outpatients aged 18 and above only, and it does not include doctor’s consultation fees or other hospital charges. Available for a limited time only, while stock lasts at our Health Screening Centre (HSC) and Outpatient Department (Geriatrics, Respiratory Medicine, Infectious Diseases, Nephrology or Rheumatology specialists). To make an appointment: 📞 03 5639 1389 (Health Screening Centre) / 03 5639 1212 (Outpatient Department)  📧 sjmc.hsc@rsdhealth.com #sjmc #subangjayamedicalcentre #respiratory #respiratoryhealth #respiratorycare #lungs #lunghealth #lungdisease #pneumonia #pneumococcal  #pneumococcalvaccination  #pneumoniaawareness #vaccine #getvaccinated

Delving deep into critical healthcare issues, our latest article by Dan Staner confronts the misconceptions surrounding RSV and underscores the vital importance of adult immunisation. Gaining clarity on these issues isn't just important—it's pivotal for safeguarding public health and well-being. Read more. #HealthcareInsights #PublicHealth #RSV #Immunisation #HealthcareEducation #GlobalHealthcare

NICE REVIEW!!! KEY POINTS - Respiratory syncytial virus (RSV) represents a substantial health burden for older adults, with high incidence and hospitalization rates that are often underestimated. - Emerging vaccines for RSV show promising efficacies up to 94.1%, marking significant progress in prevention efforts for the older adults. - Despite vaccine approvals, ongoing challenges include the need for further studies to assess real-world effectiveness and understand rare side effects.